ABOUT DANTE LABS
The company behind
the genome.
2016
Founded
Italy
Headquarters
1.2M+
Clinical Reports Delivered
80+
Countries Served
LEADERSHIP
The people behind the science.
Andrea Riposati
Chief Executive Officer
Jose Baptista
Chief Marketing Officer
Chief Science Officer
To Be Announced
Chief Medical Officer
To Be Announced
MISSION
Why this company exists.
Millions of people live with conditions that remain undiagnosed or mismanaged because their doctors lack the complete genetic picture. Standard panels test a handful of genes. Targeted tests look only where they already suspect an answer.
Dante Labs exists to close that gap. We sequence the entire human genome at 30X clinical-grade coverage and deliver physician-ready reports that can change a diagnosis, redirect a treatment plan, or provide answers that years of specialist visits could not.
We believe every person deserves access to their complete genetic information, interpreted at the highest clinical standard, at a price that does not require institutional backing.
CREDENTIALS
What the record shows.
The claims are verifiable. The certifications are public. The science is published.
CLIA Certified Laboratory
Our US laboratory holds CLIA certification, the federal standard required for clinical diagnostic testing. Results are accepted by physicians and healthcare systems nationwide.
ISO 15189 Medical Laboratory
International accreditation for medical laboratories, demonstrating competence in quality management and technical operations. Recognized across 80+ countries.
Published in Nature
Dante Labs research has been published in Nature, the world's most cited interdisciplinary science journal. Our sequencing methodology meets the standard of peer-reviewed science.
ASHG Presentations
Dante Labs has presented at the American Society of Human Genetics, the largest human genetics conference in the world, contributing to the advancement of genomic science.
NHS Clinical Case
A Dante Labs Whole Genome report was used at Queen Elizabeth University Hospital Glasgow (NHS) to identify a rare genetic condition that had gone undetected through years of standard diagnostics.
ACMG Variant Classification
All variants are classified according to ACMG guidelines, the standard framework used by clinical geneticists worldwide to assess pathogenicity and clinical significance.
GLOBAL OPERATIONS
Where we operate.
European Headquarters
Italy
Founded and headquartered in Italy. Our European operations are fully GDPR-compliant, with data processing and storage subject to the strictest privacy regulations in the world.
US Accessibility
Direct Shipping, CLIA/CAP Certified
Kits ship directly to US addresses. Samples are processed in our CLIA-certified, CAP-accredited laboratory. Results are physician-ready and accepted by US healthcare providers.
Global Reach
80+ Countries
Dante Labs serves individuals across 80+ countries. Our ISO 15189 accreditation ensures clinical-grade results are recognized by healthcare systems internationally.
A NOTE ON OUR REVIEWS
We know what you've read.
If you have searched for Dante Labs, you have likely found mixed reviews. Some of them reflect real experiences during periods of rapid growth. We take those seriously.
What does not change is the clinical infrastructure behind the test: CLIA certification, ISO 15189 accreditation, Nature-published research, ACMG-standard variant classification, and over 1.2 million clinical reports delivered to individuals and physicians across 80+ countries.
We do not ask you to take our word for it. We ask you to evaluate the credentials, the science, and the clinical record. That is the standard we hold ourselves to, and it is the standard we invite you to apply.
Continue your evaluation.
The best way to understand what we do is to look at the evidence directly.